The price of Twist Bioscience Corp (NASDAQ: TWST) closed at $34.23 in the last session, down -1.07% from day before closing price of $34.60. In other words, the price has decreased by -$0.37 from its previous closing price. On the day, 535490 shares were traded.
Ratios:
We take a closer look at TWST’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 5.51 and its Current Ratio is at 5.98. In the meantime, Its Debt-to-Equity ratio is 0.16 whereas as Long-Term Debt/Eq ratio is at 0.13.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Goldman on January 17, 2024, Upgraded its rating to Buy and sets its target price to $45 from $25 previously.
On September 27, 2023, Berenberg started tracking the stock assigning a Buy rating and target price of $27.
On January 05, 2023, Scotiabank started tracking the stock assigning a Sector Outperform rating and target price of $33.Scotiabank initiated its Sector Outperform rating on January 05, 2023, with a $33 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Mar 20 ’24 when Leproust Emily M. sold 1,128 shares for $33.52 per share. The transaction valued at 37,806 led to the insider holds 515,281 shares of the business.
Banyai William sold 442 shares of TWST for $14,814 on Mar 20 ’24. The insider now owns 346,313 shares after completing the transaction at $33.52 per share. On Mar 20 ’24, another insider, Cho Dennis, who serves as the insider of the company, sold 230 shares for $33.52 each. As a result, the insider received 7,709 and left with 81,133 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TWST now has a Market Capitalization of 2.00B and an Enterprise Value of 1.78B. For the stock, the TTM Price-to-Sale (P/S) ratio is 7.54 while its Price-to-Book (P/B) ratio in mrq is 3.35. Its current Enterprise Value per Revenue stands at 6.79 whereas that against EBITDA is -10.33.
Stock Price History:
Over the past 52 weeks, TWST has reached a high of $43.21, while it has fallen to a 52-week low of $11.46. The 50-Day Moving Average of the stock is 36.40, while the 200-Day Moving Average is calculated to be 26.17.
Shares Statistics:
According to the various share statistics, TWST traded on average about 980.19K shares per day over the past 3-months and 675.65k shares per day over the past 10 days. A total of 57.56M shares are outstanding, with a floating share count of 55.29M. Insiders hold about 4.36% of the company’s shares, while institutions hold 109.17% stake in the company. Shares short for TWST as of Feb 29, 2024 were 12.4M with a Short Ratio of 12.65, compared to 12.33M on Jan 31, 2024. Therefore, it implies a Short% of Shares Outstanding of 21.44% and a Short% of Float of 28.11%.
Earnings Estimates
The company has 9 analysts who recommend its stock at the moment. On average, analysts expect EPS of -$0.81 for the current quarter, with a high estimate of -$0.75 and a low estimate of -$0.86, while EPS last year was -$1.04. The consensus estimate for the next quarter is -$0.77, with high estimates of -$0.69 and low estimates of -$0.84.
Analysts are recommending an EPS of between -$2.84 and -$3.24 for the fiscal current year, implying an average EPS of -$3.08. EPS for the following year is -$2.7, with 9 analysts recommending between -$1.97 and -$3.29.
Revenue Estimates
A total of 9 analysts have provided revenue estimates for TWST’s current fiscal year. The highest revenue estimate was $299.96M, while the lowest revenue estimate was $290.5M, resulting in an average revenue estimate of $293.24M. In the same quarter a year ago, actual revenue was $245.11M, up 19.60% from the average estimate. Based on 9 analysts’ estimates, the company’s revenue will be $354.11M in the next fiscal year. The high estimate is $384.87M and the low estimate is $340.4M. The average revenue growth estimate for next year is up 20.80% from the average revenue estimate for this year.
